Baseline Blood Tests Required Before Starting Methotrexate
Before initiating methotrexate therapy, you must obtain: complete blood count (CBC) with differential, liver function tests (AST, ALT, albumin), serum creatinine with calculated creatinine clearance, and a chest X-ray (if not done within the past year). 1
Essential Baseline Laboratory Tests
Mandatory Tests
- Complete blood count (CBC) with differential and platelet count - to establish baseline hematologic function and detect pre-existing cytopenias 1, 2, 3, 4
- Liver function tests:
- Renal function:
Strongly Recommended Additional Tests
- Hepatitis B and C serology - to identify chronic viral hepatitis that increases hepatotoxicity risk 1, 5, 2, 6
- Chest X-ray (if not obtained within the previous year) - baseline pulmonary assessment 1
- Pregnancy test for women of childbearing potential - methotrexate is absolutely contraindicated in pregnancy 1, 5
Tests to Consider Based on Risk Factors
- HIV serology 1
- Fasting blood glucose and lipid profile - particularly relevant given psoriasis and RA comorbidities 1
- Non-invasive liver fibrosis assessment (FIB-4 score, followed by elastography if indicated) for patients with hepatotoxicity risk factors including obesity (BMI ≥30), diabetes, hyperlipidemia, alcohol use, or history of liver disease 2, 7, 8
Critical Pre-Treatment Clinical Assessment
Beyond laboratory tests, you must conduct a thorough clinical evaluation:
- Alcohol intake history - quantify consumption as this significantly increases hepatotoxicity risk 1, 5
- Medication review - identify potential drug interactions, especially NSAIDs, sulfonamides, probenecid, and other hepatotoxic or nephrotoxic agents 4
- Respiratory symptoms and history - pulmonary disease increases risk of methotrexate pneumonitis 5, 8
- Risk factors for liver disease - prior hepatotoxic drug exposure, family history of inheritable liver disease (Wilson disease, hemochromatosis, α-1 antitrypsin deficiency) 5, 2
Important Caveats
Do not delay methotrexate initiation for non-invasive liver fibrosis testing - this can be performed concurrently with treatment start in appropriate patients 7. However, methotrexate is absolutely contraindicated if baseline creatinine clearance is <60 mL/min or in patients with cirrhosis 4.
The 2020 AAD-NPF guidelines 2 represent the most recent high-quality evidence and notably no longer recommend routine baseline liver biopsy, even in patients with risk factors - a significant departure from older dermatology practice. Instead, they advocate for non-invasive assessment with FIB-4 scoring and elastography when indicated.
Patient education is mandatory before prescribing - emphasize weekly (not daily) dosing, as accidental daily administration has caused fatal toxicity 8, 4. Ensure patients understand they need effective contraception and must avoid conception for at least 3 months after stopping methotrexate 1, 2.